Cicatricial pemphigoid - An important differential diagnosis of inflammatory mucosal diseases;Das vernarbende pemphigoid - Eine wichtige differentialdiagnose entzundlicher schleimhautveranderungen

Laryngo- Rhino- Otologie

Volumn 78, Issue 11, 1999, Pages 632-637

  Baier, G ^a,b   Ziliikens, D ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

BP 180; Cicatricial pemphigoid; Diagnosis; Laminin 5; Therapy

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; DAPSONE; DEXAMETHASONE; IMMUNOGLOBULIN G;

ADULT; AGED; AUTOIMMUNE DISEASE; BLISTER; CELL INFILTRATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONJUNCTIVA; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN DEPOSITION; INFLAMMATORY CELL; LARYNX; MALE; MOUTH CAVITY; MUCOSA INFLAMMATION; MUCOUS MEMBRANE PEMPHIGOID; NOSE MUCOSA; PHARYNX; PRIORITY JOURNAL; REMISSION; SCAR FORMATION; SKIN; SKIN BIOPSY; TREATMENT PLANNING;

AGED; BASEMENT MEMBRANE; BIOPSY; COMPLEMENT C3; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MOUTH MUCOSA; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; STOMATITIS;

EID: 0032763467     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-8764     Document Type: Conference Paper

References (23)

1. Thost A. Der chronische Schleimhautpemphigus der oberen Luftwege. Arch Laryngol Rhinol 1911: 25: 459-478
2. Lever WF. Pemphigus. Baltimore: Medicine, 1953
3. Hanson RD. Olsen KD, Rogers III RS, Upper aerodigestive tract manifestations of cicatricial pemphigoid. Ann Otol Rhinol Laryngol 1988; 97: 493-499
4. Nayar M, Wojnarowska F, Venning V, Taylor CJ. Association of autoimmunity and cicatricial pemphigoid: Is there an immunogenetic basis? J Amer Acad Dermatol 1991; 25: 1011 - 1015
5. Rosenbaum MM. Cicatricial pemphigoid in a 6 year-old child. Pediatr Dermatol 1984; 2: 13-22
6. Ahmed AR, Kurgis BS, Rogers RS. Cicatricial pemphigoid. J Amer Acad Dermatol 1991; 24: 987-1001
7. Zillikens D, Rose PR, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ. Tight clustering of extracellular BP 130 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997; 109: 573-579
8. Zillikens D, Mascaro JM, Rose PR. Liu Z, Ewing SM, Caux F. Hoffmann RG, Diaz LA, Giudice GJ. A highly sensitiv enzyme-linked immunosorbent assay for the detection of circulating anti-BP 180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997; 109: 679-683
9. Appelhans M, Bonsmann G, Orge C. Bröcker EB. Dexamethason-Cyclophosphamid-Stoßtherapie bei blasenbildenden Autoimmundermatosen. Hautarzt 1993; 44: 143-147
10. Pasricha JS, Thanzama J, Khan UK. Intermittend high-dose dexamethasone-cyclophosphamide-therapy for pemphigus. Brit J Dermatol 1988; 119: 73-77
11. Foster S. Cicatricial pemphigoid. Trans Amer Ophthalmol Soc 1986; 84: 527-663
12. Balding SD, Prost C, Diaz LA, Bernard P. Bedane C, Aberdam D, Giudice GJ. Cicatricial pemphigoid antibodies react with multiple sites on the BP 180 extracellular domain. J Invest Dermatol 1996; 106: 141-146
13. Zillikens D, Giudice GJ. BP 180/type XVII collagen: Its role in acquired and inherited disorders of the dermal-epidermal junction. Arch Dermatol Res, 1999; im Druck
14. Zillikens D. Acquired skin disease of hemidesmosomes. J Dermatof Sci, 1999; im Druck
15. Foster S, Neumann R, Tauber J. Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid. Doc Ophthalmol 1992; 82: 223-229
16. Mutasim DF, Nancy JP. Pelc NJ, Anhalt GJ. Cicatricial pemphigoid. Dermatol Clin 1993; 11: 499-510
17. Bernard P, Prost C. Lecerf V, Intrator L, Combemale P, Bedane C, Roujeau J-C, Revuz J, Bonnetblanc J-M, Dubertret L Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol 1990; 94: 630-635
18. Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Brit J Dermatol 1988; 118: 31-40
19. Axt M, Wever S, Baier G, Bogdan S. HashimotoT, Bröcker E-B, Zillikens D, Das vernarbende Pemphigoid - ein therapeutisches Problem. Hautarzt 1995; 46: 620-627
20. Zillikens D, Diaz LA. Autoimmune bullous diseases. In: Burg, G, Dummer, R (Hrsg). Strategies for immunointervention in dermatology. Heidelberg, Berlin: Springer, 1997: 217-226
21. Rogers RS, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Amer Acad Dermatol 1982; 6: 215-223
22. Wozel G. Dapson - Pharmakologie. Wirkmechanismus und klinischer Einsatz. Stuttgart, New York: Thieme Verlag, 1996
23. Neumann R, Tauber J, Foster S. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmol 1991; 98: 858-862